Abstract
Homeostatic renal filtration relies on the integrity of podocytes, which function in glomerular filtration. These highly specialized cells are damaged in 90% of chronic kidney disease, representing the leading cause of end-stage renal failure. Although modest podocyte renewal has been documented in adult mice, the mechanisms regulating this process remain largely unknown and controversial. Using a mouse model of Adriamycin-induced nephropathy, we find that the recovery of filtration function requires up-regulation of the endogenous telomerase component TERT. Previous work has shown that transient overexpression of catalytically inactive TERT (i-TERTci mouse model) has an unexpected role in triggering dramatic podocyte proliferation and renewal. We therefore used this model to conduct specific and stochastic lineage-tracing strategies in combination with high throughput sequencing methods. These experiments provide evidence that TERT drives the activation and clonal expansion of podocyte progenitor cells. Our findings demonstrate that the adult kidney bears intrinsic regenerative capabilities involving the protein component of telomerase, paving the way for innovative research toward the development of chronic kidney disease therapeutics.
Similar content being viewed by others
Introduction
Chronic kidney disease (CKD) is a global pandemic characterized by progressive renal function decline ultimately leading to end-stage renal disease, and represents an important risk factor for cardiovascular diseases and premature death1. The majority of kidney diseases that progress to CKD result from the depletion of glomerular visceral cells called podocytes. Historically, these highly specialized and quiescent epithelial cells have been thought to have a severely limited capacity for renewal2,3. However, several recent lines of evidence support the idea that podocytes can be at least partially renewed in the adult kidney following injury4.
Several lineage tracing studies have shed light on the source of renal progenitor cells, capable of supporting limited podocytes renewal in the postnatal kidney. These include the parietal epithelial cells (PECs) derived from the Bowman’s capsule5,6, and cells of renin lineage (CoRL) located in the juxtaglomerular apparatus7,8,9. Although these lineage tracing studies demonstrate the kidney’s modest capacity for intrinsic podocyte renewal, the filtration function of the kidney fails to fully recover in adult mice10,11. Additionally, the effectiveness of the documented potential progenitors to reconstitute podocytes as well as the molecular signals driving podocyte renewal remain unclear. One pathway that regulates podocytes in adults implicates non-canonical activity of telomerase12. Telomerase is a ribonucleoprotein complex that consists of TERT (the telomerase reverse transcriptase catalytic subunit) and TERC (the telomerase RNA subunit encoding the template sequence that is reverse transcribed by the telomerase enzyme to telomeres). Beside its well-established role in telomere synthesis, several studies demonstrated that TERT possesses non-canonical activities that foster cancer cell proliferation and adult stem/progenitor cells activation13,14,15,16,17. In the adult kidney, podocytes bear a high sensitivity to TERT non-canonical activity, an insight that comes from experimental models in which the catalytically inactive form of TERT (TERTci)—which is unable to elongate telomeres—is conditionally overexpressed12,18. This study revealed that overexpression of TERTci in double transgenic mice (i-TERTci mice) induces reprogramming of podocyte into de-differentiated and proliferating cells. Intriguingly, after the transgenic TERTci is switch-off, there is a resurgence of quiescent and fully functional podocytes12.
To establish the role of TERT in kidney physiological regeneration, we used the Adriamycin-induced nephropathy model to cause a podocyte-specific insult and investigated the role of endogenous TERT in this context. We demonstrate that functional recovery of the kidney filtration barrier requires the upregulation of endogenous TERT expression, and identify signaling pathways involved in physiological regeneration. To assess the cascade of cellular events involved in podocyte renewal in the transgenic i-TERTci model, we carried out lineage tracing approaches using EdU-labeling strategies and an unbiased stochastic multicolor system for clonal analysis. We demonstrate that clonal expansion of progenitor cells gives rise to monoclonal glomeruli and repopulate the podocyte layer. In addition, we document the requirement of bi-allelic endogenous TERT to achieve successful recovery of the filtration function. Bulk RNA sequencing profiling further shed light on key molecular signals deployed in response to TERT, including the remodeling of the extracellular matrix, the Epithelial-to-Mesenchymal transition, and the activation of KRAS signaling. Altogether, our results reveal a central role for telomerase in modulating regenerative capabilities of the adult mammalian kidney.
Results
Renal filtration recovery in Adriamycin-induced nephropathy involves glomerular repair
Adriamycin (ADR) nephropathy has been classically described as a rodent model of chronic kidney disease19,20,21. Nonetheless, spontaneous partial proteinuria remission following ADR injection in adult mice has been reported6,22. We hypothesized that renal filtration recovery following ADR-induced nephropathy can be explained by two distinct mechanisms; i) the filtration function is ensured by the remaining healthy podocytes that compensate for the impaired sclerotic glomeruli, ii) a sufficient proportion of damaged glomeruli are repaired upon a physiological process involving podocyte renewal. To test our hypothesis, we assessed the kinetic of disease progression following ADR-induced podocyte injury (Fig. 1a). We injected 10 male and 10 female BALB/c mice with a single dose of 12 mg/kg of ADR, and we subsequently monitored proteinuria as well as urinary albumin to creatinine ratio (ACR), a parameter that takes into account animal hydration. Both proteinuria and ACR monitoring revealed that ADR induced a kidney filtration dysfunction characterized by a severe protein leakage in the urine peaking at 11 days post-ADR injection (Fig. 1b, Supplementary Fig. 1). Filtration function improved over time and regressed almost completely 32 days after ADR injection in both male and female mice (Supplementary Fig. 1). Thus, only 5 to 25% of individuals retain a kidney filtration dysfunction 32 days after ADR injection characterized by either a proteinuria or an ACR level that exceed that observed 11 days after ADR injection (Fig. 1b, red curves, Supplementary Fig. 1). These data show that injection of a single dose of ADR in both male and female BALB/c mice induces massive leak of proteins into the urine that is followed by physiological recovery of filtration function in at least 70% of treated mice. To further examine the histological characteristics associated with kidney filtration function recovery in this model, we injected BALB/c female mice with a single dose of 12 mg/kg of ADR or with saline. The kidney histology was examined at 7, 14. and 32 days post-injection (Fig. 1c). Kidneys collected 14 days after ADR injection, corresponding to 3 days after the peak of proteinuria, displayed the characteristic abnormalities of human FSGS including cellular vacuolization, and interstitial fibrosis (Fig. 1c, arrows)20. Indeed, analysis of collagen deposits using Masson’s Trichrome and Sirius Red staining showed accumulation of extracellular matrix (ECM) components in the tubulointerstitial compartment and in glomeruli 14 days after ADR injection (Fig. 1c, arrows). While kidney filtration function started to improve at 14 days after injury, the prominent fibrosis observed at that time point remained associated with abnormally high levels of proteinuria (Supplementary Fig. 1). Examination of kidneys from mice sacrificed 32 days after ADR injection revealed that tubulointerstitial fibrosis and glomerular sclerosis strikingly regressed at that time point (Fig. 1c). In addition, further quantification of glomeruli with abnormal morphology associated with sclerosis and accumulation of ECM components showed a marked normalization at 32 days after ADR injection (Figs. 1d, e). Further examination of podocytes status revealed effacement of podocyte differentiation markers WT1 and synaptopodin starting from 7 days post-ADR treatment (Fig. 1f, g). Remission of proteinuria observed 32 days after ADR injection was associated with the normalization of podocytes (Fig. 1f, g). These processes were accompanied by a moderate but significant increase in cell proliferation, a hallmark of physiological regeneration in mammalian organs23, from day 7 after ADR injection that reached a peak 14 days after ADR injection (Supplementary Fig. 2). Noteworthy, cellular proliferation observed following ADR-induced injury does not appear to occur within the glomerular compartment (Supplementary Fig. 2). Collectively, these results suggest that kidney filtration function recovery is associated with glomerular repair and podocyte renewal. Therefore, we sought out to employ the ADR model to explore telomerase functions in the spontaneous regeneration of podocytes.
Endogenous TERT is required for glomerular repair following ADR-induced nephropathy
To determine whether the repair process triggered by ADR-induced podocyte injury was associated with endogenous reactivation of TERT expression, we performed RT-qPCR on whole kidneys. This analysis revealed significant upregulation of TERT mRNA expression 7 days after ADR injection that was maintained in the time course of the experiment (Fig. 2a). Interestingly, the mice with persistent kidney filtration dysfunction at 32 days after ADR injection, as assessed by proteinuria and ACR analysis, displayed significantly lower levels of TERT mRNA when compared to the mice that recovered properly (Supplementary Fig. 3). Further in situ analysis using the highly sensitive RNA detection technique RNAscope revealed that TERT upregulation was confined to glomeruli and clusters of cells located within tubular segments of the nephron at 7 days post-ADR treatment (Fig. 2b). Noteworthy, podocytes did not appear to be the source for increased TERT mRNA level in glomeruli (Supplementary Fig. 4). These results reveal a specific upregulation of TERT in nephron compartments at an early time point following ADR-induced nephropathy.
To test the requirement of endogenous TERT in the kidney recovery response, we used TERT constitutive knockout (KO) mice in the ADR model of physiological kidney repair. Telomeres of laboratory mouse strains are longer than their human counterparts, and although telomere synthesis is abrogated in TERT KO mice, phenotypes associated with telomere attrition are not detectable in first generations TERT KO mice24,25. Thus, both heterozygous (TERTKO/WT) and first-generation (G1) homozygote TERT KO (TERTKO/KO) mice do not harbor any defect in proliferating tissues and are fertile. To test the ability of TERT KO mice to recover following ADR-induced kidney injury, we injected females G1 TERTKO/KO and TERTKO/WT mice, and females TERTWT/WT littermates, all obtained from interbreeding of TERTKO/WT BALB/c N10 mice, with a single dose of 12 mg/kg of ADR, as performed on BALB/c mice. Monitoring of proteinuria following ADR injection revealed a similar peak of proteinuria 11 days after ADR injection in TERTKO/KO, in TERTKO/WT, and in their TERTWT/WT littermates (Fig. 2c). However, in contrast to control TERTWT/WT mice, both TERTKO/KO and TERTKO/WT mice showed a more heterogeneous recovery of kidney filtration function, with latent proteinuria levels significantly higher 18 days post-ADR treatment (Fig. 2c, Supplementary Fig. 5).
To determine if the perturbed kinetic of recovery observed in TERTKO/KO and TERTKO/WT mice was associated with changes in the balance between regeneration and scarring following injury, we examined ECM deposition 32 days after ADR injection (Fig. 2d). Such analysis showed that TERTKO/KO and TERTKO/WT mice display an increased prevalence of sclerotic glomeruli when compared to TERTWT/WT mice (Fig. 2e). Those results show that invalidation of endogenous TERT results in an increased number of sclerotic glomeruli following podocyte injury, suggesting a role for endogenous TERT in kidney homeostatic repair. Importantly, the increased incidence of glomerular scarring in TERTKO/KO mice was not associated with the shortening of mean telomere DNA length (Supplementary Fig. 6). Overall, these results suggest that endogenous TERT expression is required for kidney filtration recovery and ECM remodeling, independently of its catalytic activity in telomere elongation, to achieve glomerular repair following ADR-induced nephropathy.
To gain insight into the molecular processes targeted by TERT non-canonical functions upon glomerular repair, we performed high-throughput sequencing (bulk RNA-seq) on kidneys collected from TERTKO/KO mice upon the recovery period, i.e. 18 days after ADR-injection. Comparison of TERTKO/KO and TERTWT/WT transcriptomes in saline-treated mice showed minimal changes, but suggested that TERT deficiency perturbed basal activation of several pathways including mTORC1, Wnt, and Notch signaling (Supplementary Figure 7). Further GSEA analysis of ADR-treated mice interestingly revealed that TERT deficiency precludes proper activation of signaling pathways, including Epithelial-to-Mesenchymal transition (EMT) and KRAS signaling, upon glomerular repair (Fig. 2f). In addition, assessment of Gene Ontology term (GO term) using Database for Annotation, Visualization and Integrated Discovery (DAVID) analysis highlighted impairment of extracellular matrix (ECM) remodeling upon deletion of TERT (Fig. 2g). Examination of the status of metalloproteinases (MMPs) revealed that TERT deletion prevented the upregulation of MMP-24, MMP-12, MMP-10, and MMP-3 that is normally observed in TERTWT/WT mice upon glomerular repair following ADR injury (Supplementary Fig. 8). Altogether, these results highlight key signaling pathways involved in a TERT-dependent regenerative program following ADR-induced injury.
Catalytically-inactive TERT overexpression triggers podocyte renewal from a non-podocyte source
We next aimed to better dissect the cellular mechanisms that contribute to TERT-dependent podocyte renewal using a mouse model of catalytically inactive TERT (TERTci) (Fig. 3a). We previously showed in i-TERTci mice that conditional and ubiquitous overexpression of TERTci impaired in its telomere elongation function, causes a dramatic effect on kidney podocytes proliferation that ultimately leads to a collapsing glomerulopathy reminiscent of human collapsing FSGS features12. The subsequent podocyte effacement results in severe proteinuria, a robust phenotype observed specifically in i-TERTci mice independently of their background (Supplementary Fig. 9)12. Importantly, this phenomenon is reversible following the switch-off of transgenic TERTci expression, and this reversibility is characterized by a marked improvement of kidney filtration function and re-expression of podocytes differentiation markers (Fig. 3b)12. However, the cellular mechanisms deployed to repair the glomerular compartment following a pulse of TERTci expression remain cryptic.
We first sought to determine whether renewed podocytes were emerging from simple podocyte duplication or from an external source of progenitor cell using a podocyte lineage tracing model (Fig. 3c, Supplementary Fig. 10). We first assessed the efficiency of EGFP-podocyte labeling following tamoxifen injection of WT1CreERt2;R26mTmG control mice. Toward that goal, we performed double-immunostaining for EGFP and Synaptopodin that correspond to differentiated podocytes, in whole kidney paraffin sections and established the overlap between both signals. This analysis revealed the EGFP labeling of 95.7% (± 0.94%) of the Synaptopodin positive (Syn + ) area, defined as a threshold of EGFP expression for the downstream experiments (Supplementary Fig. 10).
We next performed podocyte lineage tracing following TERTci pulse and reversal, in WT1CreERt2;R26mTmG;i-TERTci compound mice (Fig. 3c, Supplementary Fig. 10). In this experiment, the EGFP permanent labeling of mature podocytes was induced with tamoxifen treatment prior TERTci induction (TERTci ON) (Fig. 3c, Supplementary Fig. 10). Therefore, we assessed the prevalence of EGFP + area within Syn+ area at the end of the reversal period. This analysis revealed a high proportion of differentiated podocytes (Syn+ positive cells) devoid of EGFP + signal in kidneys of WT1CreERt2;R26mTmG;i-TERTci mice reversed (Fig. 3d, arrows). Thus, while EGFP tagging of podocytes remained stable over the time of the experiment in control mice with 95.5% (± 0.82%) of Syn+ area overlapping with EGFP signal, 59.7% (± 14.3%) of differentiated podocytes observed after TERTci-enforced renewal were devoid of EGFP signal (Fig. 3e). Those results show that about half of differentiated podocytes observed after a TERTci pulse in the adult kidney, ensue from cells that do not derive from initially EGFP-labeled podocytes. Double staining of kidney sections for EGFP and the transcription factor Wilms tumor protein 1 (WT1), expressed in mature podocytes, confirmed this observation (Fig. 3f, arrows). These data indicate that renewed podocyte do not emerge from podocyte duplication, suggesting that they come from an external source of progenitor cells.
Tubular epithelial cells proliferate following a TERTci pulse
A common feature of regeneration in adult tissue or organ is the activation of quiescent adult stem cells, or differentiated cells, to govern the generation of progenitor cells that rapidly divide and give rise to terminally differentiated cells26. Hence, we sought to use the i-TERTci mouse model to chase the origin of podocyte progenitors. Toward that goal, we first characterized the kinetic of cell proliferation upon TERTci-induced podocyte renewal. Dividing cells were labeled using the administration of the thymidine analogue EdU in the drinking water of mice along the time course of the reversal period (Fig. 4a). Kidneys were then collected upon the early reversal period, i.e. 8 days after switching-off TERTci expression (R8), a time point that corresponds to the early phase of proteinuria remission (Supplementary Fig. 11). Examination of EdU distribution within whole kidney sections of control mice revealed a basal level of cell proliferation within the kidney tubules (Fig. 4b, c). This result suggests that tubular epithelia undergo homeostatic turnover in steady-state conditions. Assessment of EdU distribution in the whole kidney section following a TERTci pulse revealed the specific appearance of arrays of proliferative cells within cortical tubular segments in i-TERTci mice (Fig. 4c, arrows). While those arrays of EdU+ cells represented a limited fraction of all EdU+ cells observed in whole kidney sections of i-TERTci mice (Fig. 4b, Supplementary Fig. 11), they were never observed in cortical tubular segments of control mice. To further determine the location of EdU+ cells within the nephron, we performed co-immunostaining for EdU and markers of the different sections of the nephron (Fig. 4d). Such analysis revealed that the arrays of EdU+ cells specifically observed in kidneys of i-TERTci mice were mainly located within AQP2 + collecting tubules and spread toward the NCC + distal convoluted tubules (Figs. 4e, f). Noteworthy, the number of EdU+ cells in glomeruli of i-TERTci mice remained low and similar to that observed in control actin-rtTA+ animals (Fig. 4e). Those results show that induction of cell proliferation right after silencing TERTci overexpression is mainly observed in the distal convoluted and collecting tubules, but remains low in glomeruli.
To further characterize the fate of EdU-labeled cells after the early phase of reversal, we performed a pulse-chase experiment. EdU was administrated in mice drinking water upon the first 8 days of reversal, and the mice were then switched to normal drinking water for 7 days until kidney collection (R15) (Fig. 4g). Analysis of EdU+ cells in this setting revealed an important depletion of those cells within the AQP2-expressing section of the nephron in i-TERTci mice at R15 when compared to R8 (Fig. 4h, Supplementary Fig. 11). This 77% drop in the number of EdU+ cells within the AQP2 + segment suggests that proliferation of tubular AQP2 + cells observed after TERTci switch-off is followed by an extensive renewal of this portion of the nephron. Nonetheless, specific loss of these arrays of EdU+ cells in AQP2 + segment did not involve apoptosis as assessed by TUNEL assay (Supplementary Fig. 12).
We next analyzed the distribution of EdU+ cells after the chase period and we observed a specific and significant enrichment of proliferative cells in glomeruli and proximal convoluted tubules of i-TERTci mice (Fig. 4h, i, Supplementary Fig. 11). Part of those glomerular EdU+ cells, specifically observed in glomeruli of i-TERTci mice after the chase period, expressed the podocyte differentiation marker WT1 (Fig. 4j). These tracing methods indicate that cell proliferation is initiated in the inner cortex at the early stages of the TERTci reversal period, corresponding to the distal convoluted and collecting tubules of the nephron and is further observed in the glomeruli and proximal tubules located within the outer cortex after the chase period. These results demonstrate the dynamic epithelial cell proliferation within the different segments of the nephron throughout the TERTci reversal period, suggesting the activation of transit-amplifying cells in response to TERTci expression.
Monoclonal glomeruli emerge following a telomerase pulse in the adult kidney
To further dissect the mechanisms that conduct to podocyte renewal in the transient system of TERTci overexpression, we used an unbiased approach based on the ubiquitous and stochastic multi-color labeling of the mouse body cells. The R26confetti mouse system enables the stochastic expression of membrane-targeted CFP (Cyan Fluorescent Protein), nuclear GFP (Green Fluorescent Protein), cytosolic YFP (Yellow Fluorescent Protein) or cytosolic RFP (Red Fluorescent Protein) upon Cre recombinase activation (Fig. 5a)27. This reporter mouse strain was crossed with the UBCCreERt2 mouse strain that drives ubiquitous recombination within the adult kidney upon tamoxifen treatment28. UBCCreERt2;R26confetti mice were subsequently crossed with i-TERTci mice to perform an unbiased multi-lineage tracing study upon TERTci-induced podocyte renewal (Fig. 5a). We reasoned that using sub-optimal recombination of this stochastic multicolor reporter would allow us to target a fraction of podocyte progenitor cells, and to subsequently trace them upon TERTci-induced podocyte renewal (Fig. 5a). Using spectral confocal microscopy techniques, we assessed the recombination efficiency in the kidney of control mice and observed 30.9% (± 4.7%) of recombined cells in the medulla and 47% (± 8.6%) in the cortex (Supplementary Fig. 13). We then examined glomeruli once podocyte renewal was complete and normal kidney function resumed (R30) in i-TERTci mice. While the expression pattern of the four fluorescent proteins remained stochastic in glomeruli of UBCCreERt2;R26Confetti;actin-rtTA+ control mice (Fig. 5b), the appearance of clonal cell expansions were specifically observed in glomeruli of UBCCreERt2;R26Confetti;i-TERTci mice (Fig. 5c, d, e). Surprisingly, these glomerular clones appeared to emerge from the proximal convoluted tubular cells that shape the urinary pole of glomeruli (Fig. 5c, arrows). Interestingly, these clones were not observed beyond the proximal tubule, as these arrays of clonal cells were frequently interrupted in the proximal region by unlabeled or differently labeled cells (Fig. 5d, arrow). Such clonal expansions within the proximal convoluted tubules reaching the urinary pole of glomeruli were sparsely observed in UBCCreERt2;R26Confetti;actin-rtTA+ control mice, but rarely yield emergence of clonal glomeruli such as those observed in UBCCreERt2;R26Confetti;i-TERTci mice (Fig. 5f). Immunostaining for the nuclear podocyte differentiation marker WT1 on semi-thick kidney sections from a UBCCreERt2;R26Confetti;i-TERTci mouse with GFP + clonal glomeruli revealed that 29.4% (± 3.9%) of the GFP + cells displayed podocyte differentiation marker (Fig. 5g). This result suggests that a considerable proportion of the newly generated clonal cells are directed toward a podocyte fate. We next examined the color repartition of clonal glomeruli within each kidney section and observed an intriguing clustering of single-colored glomeruli in different territories of the cortex, suggesting the location of podocyte progenitors to be further than the proximal tubule (Supplementary Fig. 14). Altogether, our unbiased lineage-tracing methods concurred in supporting the existence of podocyte progenitor cells that get activated following TERTci expression pulse and that invade the proximal convoluted tubule up to the podocyte compartment in a clonal manner.
Endogenous TERT is required for glomerular renewal following a TERTci pulse
Our results show that endogenous TERT is required for glomerular repair following injury, and that a TERTci pulse is sufficient to trigger monoclonal expansion of progenitor cells in the adult kidney. Nonetheless, glomerular renewal observed in the i-TERTci mice only starts once TERTci overexpression is silenced. To determine whether endogenous TERT is involved in podocyte renewal observed in the i-TERTci mouse model, we generated i-TERTci;TERTKO/WT compound mice. We carried out transient TERTci overexpression in these mice and monitored proteinuria. The analysis of proteinuria in individual animals throughout the time course of the experiment strikingly revealed that 7 out of 8 i-TERTci;TERTKO/WT mice displayed perturbed proteinuria remission, and significantly higher proteinuria levels at reversal day 13 and at the end of the experiment at reversal day 18 when compared to i-TERTci mice (Fig. 6a, b). Further examination of kidney histology revealed massive sclerosis in glomeruli of i-TERTci;TERTKO/WT mice (Fig. 6c, d). We next carried out podocyte count in glomeruli by quantifying WT1 + nuclei per glomerular cross-section. Such analysis showed that while mean podocyte number per glomeruli remains preserved in i-TERTci after reversal, endogenous TERT invalidation in i-TERTci;TERTKO/WT mice results in 35% of podocyte loss (Fig. 6e). These results demonstrate the intriguing role of endogenous TERT in the remission of proteinuria and resolution of glomerular scarring in the i-TERTci model and prompted further molecular studies.
TERT-induced podocyte renewal triggers modulation of genes involved in EMT, ECM remodeling, and KRAS signaling
Our results highlight the involvement of TERT non-canonical functions in glomerular renewal. To gain insight into the specific molecular targets and pathways activated in response to TERTci stimulation we performed high-throughput sequencing (bulk RNA-seq) analysis of total kidneys from i-TERTci mice. Kidneys were collected during the recovery period at reversal day 8 (R8), an early time point that corresponds to inflexion toward functional recovery of filtration function (Supplementary Fig. 15). Comparison of transcriptomes from i-TERTci vs. control actin-rtTA+ mice identified 1877 Differentially Expressed Genes (DEG) at R8 (Supplementary Fig. 15). GSEA analysis revealed enrichment of gene signatures including that of Epithelial-to-Mesenchymal Transition (EMT), extracellular matrix (ECM) remodeling, KRAS signaling, and several signatures related to inflammation (Fig. 7a). We next compared these gene signatures observed following a TERTci pulse to the gene signatures observed in a physiological regeneration context following ADR-induced injury (Fig. 7b). Such comparison highlighted six gene signatures specifically enriched in the TERTci regenerative context including Hedgehog, Wnt and Notch signaling (Fig. 7b, Supplementary Fig. 15). Interestingly, gene signatures related to inflammation were similarly enriched in both TERTci regeneration and ADR-induced physiological regeneration (Fig. 7b, c). Reactome pathway analysis confirmed similar strength of activation of the immune system in both regenerative contexts (Fig. 7d) and further revealed an increased induction of pathway related to ECM remodeling in TERTci-enforced regeneration when compared to ADR-induced physiological regeneration (Fig. 7d). The high upregulation of ECM remodeling genes in i-TERTci mice was associated with specific upregulation of three metalloproteinases, namely MMP-23, MMP-9, and MMP-2 (Supplementary Fig. 15). Altogether, the molecular profiling of the signals triggered by TERT highlight the core pathways activated upon deployment of TERT pro-regenerative functions in the adult kidney (EMT, ECM remodeling, KRAS) and further suggest the involvement of specific pathways such as Hedgehog, Wnt and Notch in a context of enforced regeneration.
Discussion
The main finding of this study is the uncovering of a key role of telomerase component TERT in glomerular repair following acute podocyte insult that conducts to normalization of proteinuria in the adult mammalian kidney. We first found that endogenous TERT is upregulated upon glomerular repair in a model of ADR-induced nephropathy, a process that involves the resolution of glomerular scarring and fibrosis that precludes regeneration (Fig. 8). The comparison of the deregulated genes identified in a bulk RNA sequencing of TERTWT/WT and TERTKO/KO total kidneys collected upon the physiological repair process further revealed that endogenous TERT regulates signals involved in Epithelial-to-Mesenchymal Transition (EMT), KRAS signaling, and remodeling of ECM components. Interestingly, the failure to repair glomeruli in the mouse model of TERT gene deficiency is observed in the first generation of TERT knock-out mice that do not show significant telomere DNA length shortening. More strikingly, heterozygous invalidation of the TERT gene also induced a dramatic failure of glomerular scarring remission, suggesting that non-canonical functions of telomerase are at play during kidney regeneration and that deployment of these functions rely on a fine dosage of TERT. We then used our previously published catalytic-dead telomerase (TERTci) mouse model to explore the non-canonical roles of telomerase in podocyte renewal12. We found that a pulse of TERTci expression is sufficient to activate a progenitor cell population that clonally expend and repopulate the podocyte compartment. We demonstrated that such activation of progenitors required endogenous TERT expression, and was associated with the activation of signaling pathways similar to those identified in a physiological regeneration context. Additionally, TERTci overexpression triggered the expression of molecular signals reminiscent of the stem/progenitor gene signature, including Hedgehog, Wnt, and Notch signaling pathways. Our approaches thus identify TERT-dependent regenerative molecular actors in the adult mammalian kidney.
Homeostatic tissue repair following acute injury relies on a complex interplay between immune cells and ECM reorganization29. This phenomenon remains transient, and successful healing depends upon a step of efficient scar resolution that precedes cell replacement30,31. In certain chronic disease conditions, excess ECM deposition leads to fibrosis, a condition driving progressive loss of tissue function. In the adult kidney, podocyte effacement conducts to capillaries clogging by ECM proteins, an effective and immediate mechanism to limit massive leakage of the essential components of the bloodstream into the urine32 (Fig. 3b). However, unresolved accumulation of ECM components in glomeruli promotes glomerulosclerosis33, a condition that may be the consequence of inadequate regenerative response following successive injuries. Our results show that TERT plays critical functions in the regulation of genes involved in scar resolution upon kidney regeneration. Such functions of TERT on tissue ECM remodeling could be a pre-requisite for progenitor cells expansion to carry out tissue repair. The unbiased bulk RNA sequencing of total kidney cells approach uncovered the modulation of the three metalloproteinases MMP-24, MMP-12 and MMP-3. It is noteworthy that MMP-3 has been described as a target of hTERT non-canonical functions in vitro34. Further studies will be needed to decipher the molecular mechanism employed by TERT to modulate the expression of its target genes in a regenerative context.
While high levels of endogenous TERT have recently been shown to mark stem/progenitor cells in adult mice35,36,37, the pro-regenerative molecular signature of TERT in vivo remains elusive. Our data unveil the core pathways involved in TERT pro-regenerative functions in the adult kidney, and implicate a KRAS molecular signature. Interestingly, activating KRAS mutation was found to synergize with high levels of endogenous TERT to initiate pancreatic tumorigenesis37. Thus, we speculate that a fine interplay between TERT and KRAS signaling is critical to drive proper tissue renewal, and that balanced activation of those two is critical to avoid deleterious consequences such as cancer initiation. Additionally, we characterized the modulation of Hedgehog, Wnt, and Notch signaling pathways upon TERTci-induced regeneration. These signaling pathways are established regulators of stem cell self-renewal, embryonic development, and differentiation, and their abnormal regulation can also conduct to tumorigenesis. While modulation of Wnt was previously shown to be involved in mediating TERT non-canonical functions12,14,18, the role of Hedgehog and Notch signaling in the deployment of TERT pro-regenerative functions remain to be explored.
A range of methods have been used in the adult mammals to identify potential podocyte progenitor cells. These strategies have led to the identification of several candidates for podocyte progenitor cells, which, depending on the study, are located within the glomerulus or within the juxtaglomerular apparatus5,6,7,38,39. The unbiased approach consisting in the stochastic multicolor tracing of random cells in the i-TERTci mice organism revealed that the adult kidney holds a population of cells capable of clonal expansion when submitted to the appropriate stimulus. The nature and localization of these cells remain enigmatic, however, we can speculate that the activation of these cells leads to the generation of podocyte progenitor cells that invade several glomeruli to restore the organ function. Interestingly, the co-localization of WT1 staining with the mono-colored glomerular cells indicates that the population of clonal cell progenitors can repopulate the podocyte layer but also potentially proximal tubular cells and other glomerular cell types such as the PEC. Several lines of evidences accumulated in this study suggest that the source of progenitor cell might represent adult stem cells, such as those described in other mammalian organs that reside within specialized microenvironments called niches40. However, it is noteworthy that recent studies conducted in organs with a well-defined stem cell niche, such as the skin and the intestine, demonstrated that the plasticity of differentiated cells significantly contribute to effective regeneration41,42. Thus, the podocyte progenitors might not emerge from a specific and dedicated cell type within its niche, but rather from cells that would display a striking and transient plasticity in response to transient TERTci expression. Further studies will be needed to unveil the origin of podocyte progenitor cells. Altogether, we consider that the i-TERTci mouse is a key model to further investigate the nature of podocyte progenitors.
Finally, a deficit of telomerase may prove to be involved in age-related renal dysfunctions, end-stage renal disease (ESRD) being an increasingly common organ failure in the aging population. Identification of pro-regenerative molecules targeted by telomerase in the adult kidney would offer new strategies that harness the organ’s intrinsic regenerative potential to delay or reverse renal disease progression.
Methods
Mice
Tetracycline-regulated i-TERTci transgenic mice, WT1CreERt2 mice (The Jackson Laboratory, stock# 010912), R26mTmG mice (The Jackson Laboratory, stock# 007576), UBCCreERt2 mice (The Jackson Laboratory, stock# 008085), R26confetti mice (The Jackson Laboratory, stock# 013731), and TERTKO mice (The Jackson Laboratory, stock# 005423) were previously described13,18,27,28,43,44,45. Mice were PCR-genotyped using the following oligonucleotide pairs: 5’-CGCCCAGAAGCTTGGTGTAG−3’, 5’-GCTCCATGGCGATGACTTAG-3’ (actin-rtTA + ); 5’-GGATGTACTTTGTTAAGGCAGCA-3’, 5’-ACAACGGAGTTCCTCAGTGC-3’ (tetop-TERTci + ); 5’-ATCGCAGGAGCGGAGAAC-3’, 5’-GCAAACGGACAGAAGCATTT-3’ (WT1CreERt2); 5’-CTCTGCTGCCTCCTGGCTTCT-3’, 5’-CGAGGCGGATCACAAGCAATA-3’, 5’-TCAATGGGCGGGGGTCGTT-3’ (R26mTmG); 5’-GACGTCACCCGTTCTGTTG-3’, 5’-AGGCAAATTTTGGTGTACGG-3’ (UBCCreERt2); 5’-GAATTAATTCCGGTATAACTTCG-3’, 5’-AAAGTCGCTCTGAGTTGTTAT-3’, 5’-CCAGATGACTACCTATCCTC-3’ (R26Confetti); 5’-CCCCAGGCGCCGCACAAAGG-3’, 5’- GGTCCTGGCTGTTTTCTAAG-3’, 5’-CTGGATTCATCGACTGTGGC-3’ (TERTKO).
Mice experiments
All mice were treated in accordance with the Institutional Animal Care and Use Committee approved guidelines at the Université Côte d’Azur (UCA, Nice, France) (CIEPAL-AZUR Agreements NCE/2012-32, NCE/2015-237#05225.03, APAFIS#2590-2015102215087555v3, APAFIS#16319-2018071917443610v2, and APAFIS#15232-2018051116515863-M20210803).
Mouse model of ADR-induced podocyte injury
A single dose of 12 mg/kg of Adriamycin (ADR, Doxorubicin Hydrochloride, Sigma, Ref# D1515) or saline (NaCl 0.9%) was injected into the tail vein of 2-3 months old BALB/c mice or TERT knockout mice backcrossed for 10 generations with BALB/c mice (N10 BALB/c mice). For the TERT knockout experiment, TERTWT/WT littermates were used as controls. For RNA-seq analysis, kidneys of TERTKO/KO and TERTWT/WT mice were collected 18 days after intravenous injection of ADR or saline (NaCl). All mice were weighed twice a week in the time course of the experiments, and urine was collected for each individual mouse twice a week. BALB/c mice were obtained from Janvier Lab (strain BALB/cJRj).
Transient TERTci overexpression in i-TERTci mice
Double transgenic i-TERTci mice encompass both actin-rtTA+ and tetOp-TERTci + transgenes, allowing doxycycline-regulated and ubiquitous expression of TERTci in those mice. Those mice are maintained at a heterozygous status for each transgene. In order to induce TERTci overexpression in adult i-TERTci mice, doxycycline (2 mg/ml in 5% sucrose) (Doxycycline Hyclate, Sigma, Ref# D9891) was administered in drinking water in light-protected bottles and changed biweekly. The actin-rtTA+ control mice followed the same treatment than i-TERTci mice. High proteinuria levels (above 10 mg/mL) were observed in i-TERTci mice at about 15 days of doxycycline treatment (D15). At that time point, the doxycycline treatment was stopped (R0, mice switched to normal drinking water), and both i-TERTci and actin-rtTA+ control mice entered a reversal period during which proteinuria gradually regressed in i-TERTci mice. Only residual proteinuria persisted after 15 to 30 days of reversal (R15-30). For RNA-seq analysis, kidneys of i-TERTci and actin-rtTA+ control mice were collected 8 days after doxycycline withdrawal (reversal day 8, R8). All mice were weighed twice a week in the time course of the experiments, and urine was collected for each individual mouse twice a week.
EdU pulse-chase experiment on i-TERTci mice
In this experiment, the actin-rtTA+ control mice followed the same treatments than i-TERTci mice. Doxycycline (2 mg/ml in 5% sucrose) was administered in drinking water in light-protected bottles and changed biweekly. High proteinuria levels (above 10 mg/mL) were observed in i-TERTci mice at about 15 days of doxycycline treatment (D15). At that time point, the doxycycline treatment was stopped (R0), and both i-TERTci and actin-rtTA+ control mice entered a reversal period during which proteinuria gradually regressed in i-TERTci mice. Once the doxycycline treatment was stopped (R0), EdU (0.4 mg/ml in 5% sucrose) (Life Technologies, Ref# E10415) was administered in drinking water in light-protected bottles and changed biweekly. The EdU treatment in drinking water was maintained for 8 days (R0-R8), and kidneys of the mice were either collected at the end of EdU treatment, 8 days after stopping doxycycline treatment (R8), or 15 days after stopping doxycycline treatment, which correspond to 7 days of EdU chase (R15). All mice were weighed twice a week in the time course of the experiments, and urine was collected for each individual mouse twice a week.
Transient TERTci overexpression in WT1CreERt2;R26mTmG;i-TERTci mice and UBCCreERt2;R26confetti;i-TERTci mice
In these experiments, the WT1CreERt2;R26mTmG;actin-rtTA+ or UBCCreERt2;R26confetti;actin-rtTA+ control mice followed the same treatments than experimental mice. Intraperitoneal injection of (Z)−4-Hydroxytamoxifen (4OHT, Sigma, Ref# H7904; 1.5 mg in corn oil) was performed for 3 consecutive days. Doxycycline treatment was started 5 days after the last 4OHT injection. Doxycycline (2 mg/ml in 5% sucrose) was administered in drinking water in light-protected bottles and changed biweekly. High proteinuria levels (above 10 mg/mL) were observed in i-TERTci mice at about 15 days of doxycycline treatment (D15). At that time point, the doxycycline treatment was stopped (R0), and both i-TERTci and actin-rtTA+ control mice entered a reversal period during which proteinuria gradually regressed in i-TERTci mice. All mice were weighed twice a week in the time course of the experiments, and urine was collected for each individual mouse twice a week.
Proteinuria analysis
Urine was collected from all individual mice before starting the experimental procedure, and twice a week in the time course of the experiment. Urine samples were assessed for protein content by the Bradford protein assay (BioRad, Ref# 5000002) and by the Albumin Creatinine Ratio Assay kit (Abcam, Ref# ab241018).
Histology
Kidneys were fixed overnight in 10% buffered formalin and embedded in paraffin. Five μm tissue sections were stained with hematoxylin and eosin (H&E), or Masson Trichrome, or Sirius Red, or Periodic acid-Schiff for microscopic analysis.
Immunohistochemistry
Antigen retrieval was performed on 5 μm paraffin sections using Vector unmasking reagent (Vector Laboratories, Ref# H3300). Mouse monoclonal primary antibodies were detected using a biotinylated anti-mouse IgG (MOM kit, Vector Laboratories, Ref# BMK-2202) followed by streptavidin-AlexaFluor647 (Jackson ImmunoResearch, Ref# 016–600). For immunostaining using rabbit, and chicken primary antibodies, kidney sections were blocked (PBS; 10 mg/ml BSA; 5% NGS; 0.01% Triton), then incubated with the primary antibody diluted in the blocking solution for overnight at 4 °C. For immunostaining using goat primary antibody, NGS was substituted by donkey serum in blocking solution. Detection was performed with a Cy3-conjugated goat anti-rabbit secondary antibody (Jackson Immunoresearch, Ref# 111–165), AlexaFluor488-conjugated goat anti-chicken secondary antibody (Jackson Immunoresearch, Ref# 103–545), and AlexaFluor594-conjugated donkey anti-goat secondary antibody (Thermo Fischer, Ref# A-11058). EdU was detected using Click-it Plus EdU AlexaFluor647 Imaging kit (Thermo Fisher, Ref# C10640).
The primary antibodies used were: Mouse Monoclonal Synaptopodin-specific (undiluted, Progen, Ref# 65194), Rabbit Monoclonal Ki67-specific (1:100, Spring Bioscience, Ref # M3062), Rabbit Monoclonal WT1-specific (1:100, AbCam, Ref# 89901), Chicken Polyclonal GFP-specific (1:300, Avès Labs, Ref# GFP-1020), Mouse Monoclonal AQP2-specific (1:100, Santa Cruz Biotechnology, Ref# sc-515770), Goat Polyclonal AQP2-specific (1:100, Santa Cruz Biotechnology, Ref# sc-9882), Mouse Monoclonal AQP1-specific (1:100, Santa Cruz Biotechnology, Ref# sc-25287), Mouse Monoclonal THP-specific (1:200, Santa Cruz Biotechnology, Ref# sc-271022), Rabbit polyclonal NCC-specific (1:100, Sigma, Ref# AB3553), biotinylated-LTL (1:200, Vector Laboratories, Ref# B1325).
Quantitative RT-PCR
Snap-frozen tissues were ground with mortar and pestle. RNA was isolated from organs by homogenization in Trizol (Thermo Fischer, Ref# 15596018), and 1 µg of total RNA was reverse-transcribed (QuantiTect Reverse Transcription kit, Qiagen, Ref# 205311), then subjected to qPCR (FastStart Universal SYBR Green Master(Rox), Roche, Ref# 4913850001) using primer pairs specific for TERT, or HPRT (5’-GACTACTCAGGTTATGCCCAG-3’, 5’-TAGACCGTGACACTTCAACC-3’ for mouse TERT; 5’-TTGCTCGAGATGTCATGAAGGA-3’, 5’-CCAGCAGGTCAGCAAAGAACT-3’ for mouse HPRT). SYBR-green analysis was performed with the 7900HT Fast Real-Time PCR System machine (ABI). The expression level of TERT was normalized to the corresponding HPRT level.
RNA in situ hybridization
Five μm thick paraffin kidney sections were processed for TERT mRNA in situ detection using the RNAscope 2.5 chromogenic Red detection kit (Advanced Cell Diagnostic), and counterstained with hematoxylin.
Tissue preparation from Confetti mice
Semi-thick sections (200μm) from native kidneys were obtained using a vibrating microtome (Microm, Ref# HM650V). Freshly cut sections were fixed in 4% paraformaldehyde at room temperature for 10 min and washed in cold PBS. Sections were then mounted on slides in Mowiol, and imaged on a spectral confocal microscope (LSM880, Zeiss), calibrated beforehand.
Whole-mount staining on semi-thick kidney sections
Semi-thick (200μm) fixed sections were blocked with TBS; 0.25% fish skin gelatin; 0.5% non-fat dry milk; 0.5% Triton, for overnight at room temperature under gentle shaking. The following day, the sections were incubated with primary antibody (rabbit monoclonal anti-WT1, AbCam, Ref# ab89901) diluted in blocking solution for overnight at room temperature under gentle shaking. The sections were then washed 3 times with PBS for 15 min, then five times with PBS; 0.5% Triton for 1 h each at room temperature under gentle shaking. Washed sections were incubated with the secondary antibody (AlexaFluor647-conjugated goat anti-rabbit, Jackson Immunoresearch, Ref# 111–605), diluted in the blocking solution for overnight at 4 °C under gentle shaking. Finally, the sections were washed 3 times with PBS for 15 min, then 5 times with PBS; 0.5% Triton for 1 h each at room temperature under gentle shaking, and mounted with Mowiol. Stained semi-thick kidney sections were imaged on a spectral confocal microscope (LSM880, Zeiss), calibrated beforehand. The percentage of glomerular GFP + cells that stain positive for WT1 was quantified on 10 independent glomeruli.
Image analysis using ImageJ software
EGFP/Synaptopodin or EdU/nephron markers double-stained kidney sections were sequentially scanned for far-red and/or red and/or green signals allowing imaging of the entire section for each fluorophore. Sirius red-stained kidney sections were similarly scanned to acquire images of the entire section. For EGFP/Synaptopodin analysis, glomeruli areas were manually demarcated on entire kidney sections based on the synaptopodin positive structures. For Sirius red analysis, glomeruli areas were manually demarcated on entire sections based on histology. Demarcated glomeruli were defined as areas to be analyzed using ImageJ software. For EdU/nephron markers analysis, the total number of EdU positive nuclei on entire sections was determined by ImageJ. The signal inherent to nephron markers was then used to designate the areas to be subsequently analyzed. The number of EdU positive nuclei within these areas was then determined by ImageJ.
RNA-seq
Total RNA was extracted from the whole kidney using the RNeasy Micro Kit with DNase treatment (Qiagen, Ref# 74004). RNA integrity was assessed using a Bioanalyzer 2100 (Agilent). Only samples with RNA Integrity Number (RIN) > 7 were further submitted to high throughput sequencing. Samples were subjected to high-output (2×100 bp) paired-end sequencing by BGI Global services (China). The quality of raw reads was assessed with FastQC. Clipping adaptor sequences were carried out using Trimmomatic and the trimmed reads were aligned to the mouse genome reference (mm10) downloaded from ENSEMBL using the STAR read aligner.
Analysis of RNA-seq data
Differentially expressed genes (DEGs) were identified using the Bioconductor package DESeq2. DEGs were considered statistically significant at an adjusted p-value (Padj) < 0.05. DEGs were then sorted by log2 fold change (log2FC), and PCA and Heatmaps were plotted to check clustering and the homogeneity of the samples. Gene set enrichment analysis (GSEA) was performed using the hallmark C7 collections on GSEA software (version 3.0) and MsigDB database and C2 (curated gene sets) database. The reported GSEA output was selected based on a normalized enrichment score (NES) > 1.05. The Database for Annotation, Visualization, and Integrated Discovery (DAVID) was used to identify the enriched pathways using gene ontology (GO) terms. The g:Profiler tool set was used to identify the enriched pathways using the Reactome database.
Statistical analysis
Data were analyzed and compared between groups using a two-tailed, unpaired Student’s t-test. A p < 0.05 was considered statistically significant and is presented as follow: * for p < 0.05, ** for p < 0.01, *** for p < 0.001.
Reporting Summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
The RNA-seq data generated and analyzed during the current study have been deposited in NCBI’s Gene Expression Omnibus (GEO) repository (Edgar et al., 2002) and are accessible through GEO Series accession number GSE190978. The other datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.
References
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296–1305 (2004).
Wiggins, R. C. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int. 71, 1205–1214 (2007).
Nagata, M. Podocyte injury and its consequences. Kidney Int. 89, 1221–1230 (2016).
Shankland, S. J., Freedman, B. S. & Pippin, J. W. Can podocytes be regenerated in adults? Curr. Opin. Nephrol. Hypertens. 26, 154–164 (2017).
Appel, D. et al. Recruitment of podocytes from glomerular parietal epithelial cells. J. Am. Soc. Nephrol. 20, 333–343 (2009).
Lasagni, L. et al. Podocyte regeneration driven by renal progenitors determines glomerular disease remission and can be pharmacologically enhanced. Stem Cell Rep. 5, 248–263 (2015).
Pippin, J. W. et al. Cells of renin lineage are progenitors of podocytes and parietal epithelial cells in experimental glomerular disease. Am. J. Pathol. 183, 542–557 (2013).
Pippin, J. W. et al. Cells of renin lineage take on a podocyte phenotype in aging nephropathy. Am. J. Physiol. Ren. Physiol. 306, F1198–F1209 (2014).
Pippin, J. W. et al. Cells of renin lineage are adult pluripotent progenitors in experimental glomerular disease. Am. J. Physiol. Ren. Physiol. 309, F341–F358 (2015).
Berger, K. et al. The regenerative potential of parietal epithelial cells in adult mice. J. Am. Soc. Nephrol. 25, 693–705 (2014).
Wanner, N. et al. Unraveling the role of podocyte turnover in glomerular aging and injury. J. Am. Soc. Nephrol. 25, 707–716 (2014).
Shkreli, M. et al. Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nat. Med. 18, 111–119 (2011).
Sarin, K. Y. et al. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 436, 1048–1052 (2005).
Park, J. I. et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 460, 66–72 (2009).
Maida, Y. et al. An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature 461, 230–235 (2009).
Ghosh, A. et al. Telomerase directly regulates NF-kappaB-dependent transcription. Nat. Cell Biol. 14, 1270–1281 (2012).
Koh, C. M. et al. Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity. J. Clin. Invest. 125, 2109–2122 (2015).
Choi, J. et al. TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet. 4, e10 (2008).
Okuda, S. et al. Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int. 29, 502–510 (1986).
Lee, V. W. & Harris, D. C. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis. Nephrology 16, 30–38 (2011).
Wang, Y., Wang, Y. P., Tay, Y. C. & Harris, D. C. Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events. Kidney Int. 58, 1797–1804 (2000).
Romoli, S. et al. CXCL12 blockade preferentially regenerates lost podocytes in cortical nephrons by targeting an intrinsic podocyte-progenitor feedback mechanism. Kidney Int. 6, 1111–1126 (2018).
Iismaa, S. E. et al. Comparative regenerative mechanisms across different mammalian tissues. NPJ Regen. Med. 3, 6 (2018).
Blasco, M. A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1, 25–34 (1997).
Chiang, Y. J. et al. Expression of telomerase RNA template, but not telomerase reverse transcriptase, is limiting for telomere length maintenance in vivo. Mol. Cell. Biol. 16, 7024–7031 (2004).
Hsu, Y. C., Li, L. & Fuchs, E. Transit-amplifying cells orchestrate stem cell activity and tissue regeneration. Cell 157, 935–949 (2014).
Snippert, H. J. et al. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 143, 134–144 (2010).
Ruzankina, Y. et al. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell 1, 113–126 (2007).
Hageman, J. H. et al. Intestinal regeneration: regulation by the microenvironment. Dev. Cell 4, 435–446 (2020).
Issa, R. et al. Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistance of activated hepatic stellate cells, and diminished hepatocyte regeneration. FASEB J. 17, 47–49 (2003).
Kallis, Y. N. et al. Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response. Gut 60, 525–533 (2011).
Fogo, A. B. Causes and pathogenesis of focal segmental glomerulosclerosis. Nat. Rev. Nephrol. 11, 76–87 (2015).
D’Agati, V. D. Pathobiology of focal segmental glomerulosclerosis: new developments. Curr. Opin. Nephrol. Hypertens. 21, 243–250 (2012).
Ding, D., Xi, P., Zhou, J., Wang, M. & Cong, Y.-S. Human telomerase reverse transcriptase regulates MMP expression independently of telomerase activity via NK-kB-dependent transcription. FASEB J. 11, 4375–4383 (2013).
Pech, M. F. et al. High telomerase is a hallmark of undifferentiated spermatogonia and is required for maintenance of male germline stem cells. Genes Dev. 29, 2420–2434 (2015).
Lin, S. et al. Distributed hepatocytes expressing telomerase repopulate the liver in homeostasis and injury. Nature 556, 244–248 (2018).
Neuhöfer, P. et al. Acinar clonal expansion in pancreas homeostasis and carcinogenesis. Nature 597, 715–719 (2021).
Kaverina, N. V. et al. Tracking the stochastic fate of cells of the renin lineage after podocyte depletion using multicolor reporters and intravital imaging. PLoS One 12, e0173891 (2017).
Eng, D. G. et al. Detection of renin lineage cell transdifferentiation to podocytes in the kidney glomerulus with dual lineage tracing. Kidney Int. 93, 1240–1246 (2018).
Blanpain, C. & Fuchs, E. Stem cell plasticity. Plasticity of epithelial stem cells in tissue regeneration. Science, 344, 1242281 (2014).
Donati, G. et al. Wounding induces dedifferentiation of epidermal Gata6+ cells and acquisition of stem cell properties. Nat. Cell Biol. 19, 603–613 (2017).
Jadhav, U. et al. Dynamic reorganization of chromatin accessibility signatures during dedifferentiation of secretory precursors into Lgr5+ intestinal stem cells. Cell Stem Cell 21, 65–77 (2017).
Zhou, B. et al. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 454, 109–113 (2008).
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L. & Luo, L. A global double-fluorescent Cre reporter mouse. Genesis 45, 593–605 (2007).
Chiang, Y. J. et al. Expression of telomerase RNA template, but not telomerase reverse transcriptase, is limiting for telomere length maintenance in vivo. Mol. Cell. Biol. 24, 7024–7031 (2004).
Acknowledgements
We thank S. Artandi at Stanford University, USA, for i-TERTci mice, A. Schedl at Institut de Biologie Valrose (iBV), Nice, France, for WT1CreERt2 and R26mTmG mice, and D. Bulavin at Institute for Research on Cancer and Aging, Nice (IRCAN), France, for R26Confetti mice. We thank S. Artandi at Stanford University, and C. Féral and D. Bulavin at IRCAN for helpful discussion and input on the manuscript. We thank M. Mondin at Institut de Biologie Valrose (iBV) for her help in calibrating the spectral confocal microscope. We thank other members of the Shkreli lab for helpful discussions and input on the manuscript. We acknowledge the IRCAN Animal core facility that is supported by “la Région Provence Alpes-Côte d’Azur” and the “Inserm”. We acknowledge the IRCAN Molecular and Cellular Imaging (PICMI) core facility that is supported by “le Cancéropôle PACA”, “la Région Provence Alpes-Côte d’Azur”, “le Conseil Départemental 06”, and the “Inserm”. We acknowledge the IRCAN Histology core facility that is supported by the “Université Côte d’Azur (UCA)” and the “Inserm”. We acknowledge the IRCAN Flow Cytometry core facility (CytoMed) that is supported by “le FEDER”, “le Ministère de l’Enseignement Supérieur”, “la Région Provence Alpes-Côte d’Azur”, “le Conseil Départemental 06”, “l’ITMO Cancer Aviesan (plan cancer)”, “le Cancéropôle PACA”, “le CNRS” and the “Inserm”. We acknowledge “HISTALIM” that provided support for histological analysis. M.M. was supported by “la Région Sud” and the “Inserm”. T.H. was supported by “la Région Sud” and the French Government (National Research Agency, ANR) through the “Investments for the Future” programs LABEX SIGNALIFE ANR-11-LABX-0028-01 and IDEX UCAJedi ANR-15-IDEX-01. L.Y. and L.C.D. were supported by “la Ligue Nationale Contre le Cancer”. N.S. was supported by “la Ligue Nationale Contre le Cancer” and by the “Fondation ARC”. This work in the M.S. lab was supported by an “ATIP-Avenir” grant from the “Inserm/CNRS”, a “dotation jeune chercheur” from the Inserm, a grant “AMGEN” from “La Société Francophone de Néphrologie, Dialyse et Transplantation (SFNDT)”, and a grant “Emergence” from the “Cancéropôle PACA”. The E.G. lab is supported by the “Inserm” cross cutting program “AGEMED”, the “ANR TELOPOST” and the “Fondation ARC”. The Shkreli lab greatly acknowledge “la Ligue Nationale Contre le Cancer” for their steady and tremendous support.
Author information
Authors and Affiliations
Contributions
M.S. conceived and led the project. M.M., T.H., L.Y., E.G., and M.S. designed the experiments. M.M., T.H., L.Y., L.C.D., J.F., M.P., O.C., and M.S. analyzed the data. M.M., T.H., L.Y., L.C.D., C.P., N.S., L.C., V.V., J.F., and M.S. performed the experiments. M.M., T.H., and M.S. wrote the manuscript. The co-first authors M.M. and T.H. contributed equally to designing the experiments, performing the experiments, analyzing the experiments, and writing the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Montandon, M., Hamidouche, T., Yart, L. et al. Telomerase is required for glomerular renewal in kidneys of adult mice. npj Regen Med 7, 15 (2022). https://doi.org/10.1038/s41536-022-00212-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41536-022-00212-z